Obesity Management Training for Obesity
(ROGMF-2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new program designed to help doctors manage obesity more effectively. The program, a 2-day preceptorship on obesity management, combines hands-on learning with online support to enhance how doctors assist patients with weight loss, particularly those with high blood pressure, type 2 diabetes, or blood sugar issues. The trial includes two groups: one receiving this new training and one without any intervention. It seeks patients who have had at least four doctor visits in the past two years for these conditions and maintain stable medication routines. As an unphased trial, this study provides a unique opportunity to contribute to improving obesity management practices.
Do I need to stop my current medications for this trial?
The trial protocol does not specify if you need to stop your current medications. However, if your medication has changed in the last 6 months, you may not be eligible to participate.
What prior data suggests that this program is safe for obesity management?
Research has shown that educational programs for managing obesity, such as a 2-day training session, are safe for participants. These sessions have not reported any negative effects. In fact, studies indicate that these programs boost primary care doctors' confidence and positivity in treating obesity. This demonstrates that the training is both safe and effective in enhancing doctors' skills and attitudes. There is no need to worry about safety with this type of educational program.12345
Why are researchers excited about this trial?
Researchers are excited about the 2-day preceptorship on obesity management because it offers an innovative approach through intensive training combined with e-learning. Unlike traditional methods that focus primarily on diet and medication, this treatment emphasizes enhancing healthcare providers’ skills and knowledge, potentially leading to more effective patient interactions and management strategies. By equipping providers with up-to-date, practical tools, this approach has the potential to improve patient outcomes and engagement in managing obesity more effectively.
What evidence suggests that this obesity management training is effective for improving obesity management?
Research has shown that a 2-day training program on obesity management can greatly improve primary care doctors' attitudes and confidence in treating obesity. In this trial, some participants will receive preceptorships with e-learning, while others will be in a control group with no intervention. Doctors who participated in these hands-on sessions reported positive changes in their medical practice. These improvements persisted even a year later, indicating long-term benefits. The program aims to help doctors better manage weight loss and related health issues like high blood pressure, type 2 diabetes, and high blood sugar. Overall, this approach has proven to make obesity management more effective in primary care settings.12678
Who Is on the Research Team?
Marie-France Langlois, MD
Principal Investigator
Université de Sherbrooke
Are You a Good Fit for This Trial?
This trial is for patients who have had at least four documented visits in the past two years for conditions like hypertension, type 2 diabetes, or impaired glucose tolerance. It's designed to help primary care physician teams improve their management of obesity.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preceptorship and Virtual Learning
Participants undergo preceptorships combined with a virtual learning community to enhance obesity management skills
Follow-up
Participants are monitored for changes in practice and self-efficacy in obesity management
What Are the Treatments Tested in This Trial?
Interventions
- 2-day preceptorship on obesity management
Find a Clinic Near You
Who Is Running the Clinical Trial?
Université de Sherbrooke
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator